newsfilter
← Latest News
GlobeNewswire·

CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th

VANCOUVER, Wash., Sept. 15, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized